Esperion Therapeutics (ESPR) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026)
Esperion Therapeutics (ESPR) Property, Plant & Equipment (Net) Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -11.41% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 8.48% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 27.10% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -7.49% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.12% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 11.74% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -11.76% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 7.32% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | 55.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.32% |
| Dec 31, 2025 | 27.26% |
| Sep 30, 2025 | -11.91% |
| Jun 30, 2025 | -17.73% |
| Mar 31, 2025 | -23.59% |
| Dec 31, 2024 | -27.41% |
| Sep 30, 2024 | -29.94% |
| Jun 30, 2024 | -31.85% |
| Mar 31, 2024 | -37.97% |
| Sep 30, 2023 | -83.79% |
| Jun 30, 2023 | -72.34% |
| Mar 31, 2023 | -61.43% |
| Dec 31, 2022 | -47.68% |
| Sep 30, 2022 | -35.59% |
| Jun 30, 2022 | -26.33% |
| Mar 31, 2022 | 5.19% |
| Dec 31, 2021 | 8.49% |
| Sep 30, 2021 | 11.91% |
| Jun 30, 2021 | 46.11% |
| Mar 31, 2021 | 44.27% |